Global Age Related Macular Degeneration (AMD) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

December 2018 | 134 pages | ID: G409CE95A26EN
GlobalInfoResearch

Abstracts

Scope of the Report:

This report studies the Age Related Macular Degeneration (AMD) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Age Related Macular Degeneration (AMD) market by product type and applications/end industries.
Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.
The global Age Related Macular Degeneration (AMD) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Age Related Macular Degeneration (AMD).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Bayer
• F. HoffmannLa Roche
• Regeneron
• Novartis
• Valeant
• Pfizer

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Wet AMD
• Dry AMD

Market Segment by Applications, can be divided into

• Men
• Woman
  

Contents

1 AGE RELATED MACULAR DEGENERATION (AMD) MARKET OVERVIEW

1.1 Product Overview and Scope of Age Related Macular Degeneration (AMD)
1.2 Classification of Age Related Macular Degeneration (AMD) by Types
  1.2.1 Global Age Related Macular Degeneration (AMD) Revenue Comparison by Types (2017-2023)
  1.2.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Types in 2017
  1.2.3 Wet AMD
  1.2.4 Dry AMD
1.3 Global Age Related Macular Degeneration (AMD) Market by Application
  1.3.1 Global Age Related Macular Degeneration (AMD) Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Men
  1.3.3 Woman
1.4 Global Age Related Macular Degeneration (AMD) Market by Regions
  1.4.1 Global Age Related Macular Degeneration (AMD) Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Age Related Macular Degeneration (AMD) Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Age Related Macular Degeneration (AMD) Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Age Related Macular Degeneration (AMD) Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Age Related Macular Degeneration (AMD) Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Age Related Macular Degeneration (AMD) Status and Prospect (2013-2023)
1.5 Global Market Size of Age Related Macular Degeneration (AMD) (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Bayer
  2.1.1 Business Overview
  2.1.2 Age Related Macular Degeneration (AMD) Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Bayer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)
2.2 F. HoffmannLa Roche
  2.2.1 Business Overview
  2.2.2 Age Related Macular Degeneration (AMD) Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Regeneron
  2.3.1 Business Overview
  2.3.2 Age Related Macular Degeneration (AMD) Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Regeneron Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
  2.4.1 Business Overview
  2.4.2 Age Related Macular Degeneration (AMD) Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Novartis Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Valeant
  2.5.1 Business Overview
  2.5.2 Age Related Macular Degeneration (AMD) Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Valeant Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pfizer
  2.6.1 Business Overview
  2.6.2 Age Related Macular Degeneration (AMD) Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Pfizer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL AGE RELATED MACULAR DEGENERATION (AMD) MARKET COMPETITION, BY PLAYERS

3.1 Global Age Related Macular Degeneration (AMD) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Age Related Macular Degeneration (AMD) Players Market Share
  3.2.2 Top 10 Age Related Macular Degeneration (AMD) Players Market Share
3.3 Market Competition Trend

4 GLOBAL AGE RELATED MACULAR DEGENERATION (AMD) MARKET SIZE BY REGIONS

4.1 Global Age Related Macular Degeneration (AMD) Revenue and Market Share by Regions
4.2 North America Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
4.3 Europe Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
4.5 South America Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA AGE RELATED MACULAR DEGENERATION (AMD) REVENUE BY COUNTRIES

5.1 North America Age Related Macular Degeneration (AMD) Revenue by Countries (2013-2018)
5.2 USA Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
5.3 Canada Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
5.4 Mexico Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

6 EUROPE AGE RELATED MACULAR DEGENERATION (AMD) REVENUE BY COUNTRIES

6.1 Europe Age Related Macular Degeneration (AMD) Revenue by Countries (2013-2018)
6.2 Germany Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
6.3 UK Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
6.4 France Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
6.5 Russia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
6.6 Italy Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC AGE RELATED MACULAR DEGENERATION (AMD) REVENUE BY COUNTRIES

7.1 Asia-Pacific Age Related Macular Degeneration (AMD) Revenue by Countries (2013-2018)
7.2 China Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
7.3 Japan Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
7.4 Korea Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
7.5 India Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA AGE RELATED MACULAR DEGENERATION (AMD) REVENUE BY COUNTRIES

8.1 South America Age Related Macular Degeneration (AMD) Revenue by Countries (2013-2018)
8.2 Brazil Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
8.3 Argentina Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
8.4 Colombia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE AGE RELATED MACULAR DEGENERATION (AMD) BY COUNTRIES

9.1 Middle East and Africa Age Related Macular Degeneration (AMD) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
9.3 UAE Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
9.4 Egypt Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)
9.6 South Africa Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

10 GLOBAL AGE RELATED MACULAR DEGENERATION (AMD) MARKET SEGMENT BY TYPE

10.1 Global Age Related Macular Degeneration (AMD) Revenue and Market Share by Type (2013-2018)
10.2 Global Age Related Macular Degeneration (AMD) Market Forecast by Type (2018-2023)
10.3 Wet AMD Revenue Growth Rate (2013-2023)
10.4 Dry AMD Revenue Growth Rate (2013-2023)

11 GLOBAL AGE RELATED MACULAR DEGENERATION (AMD) MARKET SEGMENT BY APPLICATION

11.1 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2013-2018)
11.2 Age Related Macular Degeneration (AMD) Market Forecast by Application (2018-2023)
11.3 Men Revenue Growth (2013-2018)
11.4 Woman Revenue Growth (2013-2018)

12 GLOBAL AGE RELATED MACULAR DEGENERATION (AMD) MARKET SIZE FORECAST (2018-2023)

12.1 Global Age Related Macular Degeneration (AMD) Market Size Forecast (2018-2023)
12.2 Global Age Related Macular Degeneration (AMD) Market Forecast by Regions (2018-2023)
12.3 North America Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)
12.4 Europe Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)
12.6 South America Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Age Related Macular Degeneration (AMD) Picture
Table Product Specifications of Age Related Macular Degeneration (AMD)
Table Global Age Related Macular Degeneration (AMD) and Revenue (Millio